Study of First Next Generation mRNA Bird Flu Shots in Cattle Published
Researchers at the University of Pennsylvania have published a study based on their experimental use of a next generation mRNA bird flu vaccine tested on cattle.1 Last year, the U.S. Department of Agriculture (USDA) agreed to give the novel mRNA biological developed by the University of Pennsylvania to cattle in an attempt to protect dairy […]
ACIP Reports on First “Do-It-Yourself at Home” Nasal Flu Shot
In September 2024, the U.S. Food and Drug Administration (FDA) licensed the first of its kind live attenuated nasal spray influenza vaccine to be administered at home during the 2024-2025 “flu season.” Adults up to the 49 years of age are eligible to self-administer the FluMist Home vaccine or give it to their children aged […]
COVID Shot Injury Claims Rarely Being Paid by U.S. Government
A report from the U.S. Government Accountability Office (GAO) showed that claims made under the Health and Human Services (HHS) Countermeasures Injury Compensation Program (CICP) during the first few years of the COVID-19 pandemic have risen 27 percent since the program started receiving claims in 2009. However, only three percent of the COVID shot injury […]
Influenza Vaccines Only 42 Percent Effective in Adults This Year
The influenza vaccines currently being administered in the United States are estimated by the U.S. Centers for Disease Control and Prevention (CDC) to be 42 percent effective in adults. This is an interim estimate for the 2023-2024 “flu season” published in the agency’s Morbidity and Mortality Weekly Report (MMWR) on Feb. 29, 2024.1 2 3 […]
Trust “The Science”? No.
Thanksgiving weekend came and went in 2021. The soothsayers of Team Apocalypse were wrong again—the sky didn’t fall. Whole populations of families who dared to get together to celebrate were not wiped out. But that didn’t stop NIAID Director Dr. Anthony Fauci. The COVID fatality rate doesn’t hold a candle to the risk of standing […]
Peruvian Man Suffers Guillain-Barré-like Symptoms After Receiving Sinopharm COVID-19 Vaccine
On Dec. 11, 2020, Peru’s National Institute of Health (INS) said it was temporarily suspending the Phase 1 clinical trial of an experimental COVID-19 vaccine developed by Sinopharm Group Co. Ltd. of Shanghai, China after one of the participants in the trial who got the vaccine showed difficulty in moving his arms and legs—symptoms of […]